Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran

Kidney International

Volumn 59, Issue 2, 2001, Pages 764-773

  Reddy, Dheerendra K ^a   Moore, Harold L ^a   Ho Lee, Jeong ^a   Saran, Rajiv ^a   Nolph, Karl D ^a   Khanna, Ramesh ^a   Twardowski, Zbylut J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Adequate dialysis; Anemia; Chronic renal failure; End stage renal disease; Erythropoietin; Red blood cells

Indexed keywords

DIANEAL; IRON; IRON DEXTRAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEMATOCRIT; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; RAT;

EID: 0035132553     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.059002764.x     Document Type: Article

References (46)

1. The kidney and erythropoiesis
2. Anemia of end stage renal disease (ESRD)
3. Red cell life span in nephritis and in hepatic cirrhosis
4. Isotope investigations of red cell production and destruction in chronic renal disease
5. Red cell metabolism and haemolysis in patients on dialysis
6. Inhibition of cell proliferation in renal failure and its significance to the uraemic syndrome: A review
7. Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure
8. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure
9. Mechanism of the anemia of chronic renal failure
10. The bleeding disorder of uraemia: A qualitative platelet defect
11. Role of kidney in erythropoiesis
12. Correction of anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial
13. Iron status in patients receiving erythropoietin for dialysis-associated anemia
14. Detection of functional iron deficiency during erythropoietin treatment: A new approach
15. Iron management in end-stage renal disease
16. Comparative effects of erythropoie-tin with oral iron in peritoneal dialysis and hemodialysis patients
17. Iron supplementation of hemodialysis patients receiving recombinant human erythropoietin therapy
18. Iron dextran treatment in peritoneal dialysis patients on erythropoietin
19. Failure of CAPD patients to respond to an oral iron absorption test
20. Safety of IV iron dextran in hemodialysis patients
21. Anaphylactoid reaction to dextran
22. Intravenous iron dextran in clinical medicine
23. Sarcoma after injection of intramuscular iron
24. Sarcoma after intramuscular iron injection
25. Absorption of iron from the peritoneal cavity of rats
26. Chronic administration of iron dextran into the peritoneal cavity of rats
27. The absence of toxicity in intraperitoneal iron dextran administration: A functional and histological analysis
28. Iron exchange in the rat
29. Structure of iron dextran complex
30. The effect of antibiotic prophylaxis on the healing of exit sites of peritoneal dialysis catheters in rats
31. Abdominal wall thickness as a means of assessing peritoneal fibrosis in mice
32. Observations on the peritoneum as an absorbing surface
33. Total dose iron therapy using iron dextran by intra-peritoneal route
34. Do pregnant women take their iron?
35. Side effects of oral iron therapy: A double-blind study of different iron compounds in tablet form
36. A study of erythropoiesis and iron metabolism in the rabbit in vivo
37. Oxidative damage to lipids and DNA concurrent with decrease of anti-oxidants in rat testes after acute iron intoxication
38. Dialysate to blood transport of macromolecules during peritoneal dialysis
39. Bidirectional peritoneal transport of immunoglobulin in rats: Compartmental kinetics
40. Bidirectional peritoneal transport of immunoglobulin in rats: Compartmental kinetics
41. Iron absorption and iron status in patients with chronic uremia on regular peritoneal dialysis
42. Enhancement of bacterial infection by ferric iron: Kinetics, mechanisms
43. Enhancement of acute bacterial infections in rats and mice by iron and their inhibition by human transferrin
44. Longitudinal changes in the peritoneal membrane transport kinetics in normal rats
45. Pathogenesis of peritoneal fibrosing syndromes in peritoneal dialysis